These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39315101)

  • 1. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y; Liu X; Chen W; Yu Y; Meng J; Wang J
    Front Immunol; 2024; 15():1469919. PubMed ID: 39315101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B; Colliou N; Zadeh M; Ge Y; Gong M; Owen JL; Valletti M; Jobin C; Mohamadzadeh M
    Vaccine; 2018 Jan; 36(1):155-164. PubMed ID: 29180028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.
    Gil LA; da Cunha CE; Moreira GM; Salvarani FM; Assis RA; Lobato FC; Mendonça M; Dellagostin OA; Conceição FR
    PLoS One; 2013; 8(7):e69692. PubMed ID: 23936080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y; Yu J; Li N; Wang S; Yu W; Sun Z
    Vaccine; 2009 Oct; 27(44):6148-53. PubMed ID: 19712769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Khouri JM; Motter RN; Arnon SS
    Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
    Shi DY; Chen BY; Mao YY; Zhou G; Lu JS; Yu YZ; Zhou XW; Sun ZW
    Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL; Gao S; Kang L; Nie C; Wang JL
    Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY; Liu FJ; Mao YY; Cui RT; Lu JS; Yu YZ; Dong XJ; Yang ZX; Sun ZW; Pang XB
    Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E.
    Li Z; Lu J; Tan X; Wang R; Xu Q; Yu Y; Yang Z
    Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202162
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant L-HN Fusion Antigen Derived from the L and HN Domains of Botulinum Neurotoxin B Stimulates a Protective Antibody Response Against Active Neurotoxin.
    Li Z; Lu JS; Liu S; Wang R; Xu Q; Yu YZ; Yang ZX
    Neurotox Res; 2021 Aug; 39(4):1044-1053. PubMed ID: 33616873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.
    Ruwona TB; Xu H; Li J; Diaz-Arévalo D; Kumar A; Zeng M; Cui Z
    Hum Vaccin Immunother; 2016 May; 12(5):1188-92. PubMed ID: 26837242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
    White DM; Pellett S; Jensen MA; Tepp WH; Johnson EA; Arnason BG
    Infect Immun; 2011 Aug; 79(8):3388-96. PubMed ID: 21576339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against botulism.
    Karalewitz AP; Barbieri JT
    Curr Opin Microbiol; 2012 Jun; 15(3):317-24. PubMed ID: 22694934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.